Fulcrum therapeutics presents data for potential fshd biomarker and clinical outcome assessments at 2021 muscular dystrophy association (mda) virtual clinical & scientific conference

– demonstrated whole-body mri captures heterogeneity and provides key disease severity and progression information correlated with fshd clinical endpoints –
FULC Ratings Summary
FULC Quant Ranking